“In GA, light is not transduced into electrical signals because of a loss of photoreceptors, which leads to an absolute scotoma (blind spot). 2,3 The PRIMA neurostimulation system replaces the lost ...

Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating ...

A new study published in Clinical & Experimental Ophthalmology found that faricimab was effective in treating patients with neovascular age-related macular degeneration (nAMD) who had not previously ...

Raleigh, NC - February 04, 2026 - PRESSADVANTAGE - Porter Ophthalmology announced the release of a comprehensive new ...

Ocular Therapeutix's current wet AMD treatment is dominated by anti-VEGF drugs, with EYLEA holding a 63% global market share in 2024. Read why OCUL stock is a sell.

Research conducted by design firm Quinn Evans shows how designers can increase the circadian health potential of existing ...

SHANGHAI, SHANGHAI, CHINA, January 19, 2026 /EINPresswire.com/ -- In the highly competitive and technologically driven ...

Visual IQ isn't just about finding hidden objects but is a measure of your visual-spatial intelligence. How fast and ...

Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”), an integrated biopharmaceutical company committed to redefining the retina ...

There have been some truly perfect cinematic experiences released in the past 100 years, including the likes of Casablanca, Jaws, and Parasite.

Enrollment for 4FRONT-1, the first registrational trial for 4D-150 in wet AMD, was completed within an approximately 11-month period, ahead of ...